Nitipong PermpalungSupakanya WongrakpanichSira KorpaisarnPansakorn TanratanaJaruboot AngsanakulColumbia University, College of Physicians and SurgeonsQueen Savang Vadhana Memorial HospitalMahidol UniversityUniversity of Wisconsin School of Medicine and Public HealthWHO Collaborating Center for Research on Rabies Pathogenesis and Prevention2018-10-192018-10-192013-08-28Vaccine. Vol.31, No.38 (2013), 4079-4083187325180264410X2-s2.0-84881553522https://repository.li.mahidol.ac.th/handle/20.500.14594/31237Rabies is a fatal infectious disease. Because prevention is the key management for rabies, many vaccination regimens have been developed and used worldwide. The aims for developing rabies vaccination regimens include decreasing the number and amount of dosages, decreasing the duration and the number of clinical visits, and reducing cost. Interestingly, some intradermal (ID) regimens have proved to be as effective as the standard intramuscular (IM) regimens, and have been increasingly used in developing countries because they are less expensive. In this article, we reviewed rabies vaccines based on results obtained from clinical trials and international treatment guidelines for post-exposure prophylaxis, pre-exposure prophylaxis for the high risk group, and booster vaccination. © 2013 Elsevier Ltd.Mahidol UniversityBiochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyMedicineVeterinaryReviewSCOPUS10.1016/j.vaccine.2013.06.083